SpringWorks Therapeutics Announces Clinical Collaboration with AbbVie to Evaluate Nirogacestat in Combination with ABBV-383 in Patients with Relapsed or Refractory Multiple Myeloma

NEXT STORY
Clene Nanomedicine to Present RESCUE-ALS Phase 2 Data in Late-Breaking Session at 32nd International Symposium on ALS/MND
PREV STORY
Advanced Materials in Biosensors Emerging Opportunities 2021: Advancements in Materials Enabling Flexible Hybrid Electronics Trend in Industries
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces Full Results from Positive MAP US Phase 3 Study and Supportive Top-Line Results from MAP US2 Open-Label Extension Study with RHB-104 in Crohn’s Disease

author_avatar
NASDAQ Market News

TYMLOS Label and Business Update

author_avatar
NASDAQ Market News

Investigation Report on China’s Entecavir (Bristol-Myers Squibb) Market, 2018-2022 Featuring Chia Tai Tianqing, Sino-American Shanghai Squibb, Jiangxi Qingfeng, Suzhou Dawnrays, & Fujian Cosunter

Dublin, Jan. 17, 2019 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Entecavir Market, ...

author_avatar
NASDAQ Market News